Skip to main content
Clinical Trials/IRCT20130812014333N184
IRCT20130812014333N184
Recruiting
未知

Evaluation of the therapeutic efficiency of the placenta mesenchymal stem cell-derived exosomes on the improvement of interstitial lung disease symptoms in systemic sclerosis patients, a single-arm trial.

Kermanshah University of Medical Sciences0 sites10 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kermanshah University of Medical Sciences
Enrollment
10
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • American College of Rheumatology (ACR) and EULAR2013 diagnostic criteria for systemic sclerosis
  • Intestinal lung disease confirmed by chest CT scan and lung function tests

Exclusion Criteria

  • Suffering from other autoimmune diseases
  • Uncontrolled high blood pressure, diabetes, and other endocrine disorders
  • Cardiovascular failure
  • Chronic renal failure
  • Hepatic impairment
  • Existence of life\-threatening conflicts including severe platelet hemolysis below 40,000
  • Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials